Increased adipose tissue inflammation in CKD patients is independent of obesity status [26,45,83] but at the same time obesity-associated changes in fat mass in CKD patients also correlate with CRP levels and soluble CD163 levels, which is an activated macrophage marker [84]. This evidence concerns the gene CD163 and obesity disorder.